Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic target Eli lilly GLP1 peptides for managing metabolic disorders. These naturally occurring molecules are secreted by the gut in response to meal intake, stimulating insulin secretion and suppressing glucagon release. GLP-1 peptides demonstrate promising therapeutic o